shows RT-PCR results in a CKS patient found positive to all three markers. Samples showing no specific amplification for individual MA markers (as confirmed by specific hybridizations) and expression of GAPDH mRNA (a housekeeping gene product as RT-PCR positive control) were considered negative.
Detection of MA markers in peripheral blood of CKS patients was very striking; almost all of them (20 of 21, 95%) were found positive to at least one marker. In particular, p97 was the most expressed marker (19 of 21; 90%), followed by MelanA/MARTl (11 of 21; 52%), and tyrosinase (3 of 21; 14%). Univariate analysis showed no significant correlation between stage of disease and increasing number of PCR-positive markers.
Previoulsy, we and others have observed minimal expression of these MA markers in peripheral blood of nonmelanoma controls, suggesting their high specificity for cells of melanocytic origin [2, 4] . One could speculate that detection of MA markers in peripheral blood of CKS patients could be either expression of circulating cells of the melanocytic lineage (somehow CKS-induced) or due to the presence of metastatic CKS cells expressing such antigens (in this case, specificity of such markers for MM has to be slightly reviewed). Nonetheless, some clinical and pathological correlations between CKS and MM have been described. In particular, some immunohistochemical properties are shared by these two tumors, and patients with a diagnosis of primary CKS possess a higher risk of developing MM [1] . Further studies and larger number of CKS patients are needed to better define the clinical significance of these findings. 
